Solvotrin Therapeutics
- Total Funding$4.4 M
OverviewSuggest Edit
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. Its main product is ActiveIron that is based on the iron-whey protein complex.
| Type | Private | |
| Founded | 2009 | |
| HQ | IE | Map |
| Website | solvotrin.com |
Locations
Latest Updates
| Employees (est.) (Aug 2022) | 18 | |
| Cybersecurity rating | A | More |
Key People/Management at Solvotrin Therapeutics
Pat O'Flynn
President/CEO
Mark Ledwidge
Vice President Development and Strategy
John Gilmer
Vice President Research & Development
George Walsh
Chief Financial Officer
Ronan McClafferty
Global Commercial Director
Solvotrin Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2009 |
Solvotrin Therapeutics total Funding | $4.4 m |
Solvotrin Therapeutics latest funding size | $2.14 m |
Time since last funding | 6 years ago |
Solvotrin Therapeutics investors | Enterprise Ireland, Elkstone Capital Partners, Kevin Fielding |
Solvotrin Therapeutics's latest funding round in February 2017 was reported to be $2.1 m. In total, Solvotrin Therapeutics has raised $4.4 m
Solvotrin Therapeutics Cybersecurity Score
Solvotrin Therapeutics Online and Social Media Presence
Solvotrin Therapeutics's Trends
Solvotrin Therapeutics Frequently Asked Questions
When was Solvotrin Therapeutics founded?
Solvotrin Therapeutics was founded in 2009.
Who are Solvotrin Therapeutics key executives?
Solvotrin Therapeutics's key executives are Pat O'Flynn, Mark Ledwidge and John Gilmer.
How many employees does Solvotrin Therapeutics have?
Solvotrin Therapeutics has 18 employees.
Who are Solvotrin Therapeutics competitors?
Competitors of Solvotrin Therapeutics include Alembic Pharmaceuticals, EMS Pharma and Cipla.
Where are Solvotrin Therapeutics offices?
Solvotrin Therapeutics has an office in.
How many offices does Solvotrin Therapeutics have?
Solvotrin Therapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies